LRP6 Transduces a Canonical Wnt Signal Independently of Axin Degradation by Inhibiting GSK3’S Phosphorylation of -Catenin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
AXIN1 Protein Full-Length Recombinant Human Protein Expressed in Sf9 Cells
Catalog # Aliquot Size A71-30G-20 20 µg A71-30G-50 50 µg AXIN1 Protein Full-length recombinant human protein expressed in Sf9 cells Catalog # A71-30G Lot # E3330-6 Product Description Purity Full-length recombinant human AXIN1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. This gene accession number is BC044648. The purity of AXIN1 protein was Gene Aliases determined to be >75% by densitometry. AXIN; MGC52315 Approx. MW 135 kDa. Formulation Recombinant protein stored in 50mM Tris-HCl, pH 7.5, 50mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM DTT, 0.1mM PMSF, 25% glycerol. Storage and Stability Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. Scientific Background AXIN 1 encodes a cytoplasmic protein which contains a regulation of G-protein signaling (RGS) domain and a dishevelled and axin (DIX) domain that interacts with adenomatosis polyposis coli, catenin beta-1, glycogen synthase kinase 3 beta, protein phosphate 2, and itself. AXIN1 has both positive and negative regulatory roles in Wnt-beta-catenin signaling. AXIN1 is a core component of a 'destruction complex' that promotes AXIN1 Protein phosphorylation and polyubiquitination of cytoplasmic beta- Full-length recombinant human protein expressed in Sf9 cells catenin, resulting in beta-catenin proteasomal degradation in the absence of Wnt signaling. Nuclear accumulation of AXIN1 can Catalog # A71-30G positively influence beta-catenin-mediated transcription during Lot # E3330-6 Wnt signalling and can induce apoptosis (1). -
The Wnt Pathway Scaffold Protein Axin Promotes Signaling Specificity by Suppressing Competing Kinase Reactions
bioRxiv preprint doi: https://doi.org/10.1101/768242; this version posted September 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The Wnt pathway scaffold protein Axin promotes signaling specificity by suppressing competing kinase reactions Maire Gavagan1,2, Erin Fagnan1,2, Elizabeth B. Speltz1, and Jesse G. Zalatan1,* 1Department of Chemistry, University of Washington, Seattle, WA 98195, USA 2These authors contributed equally to this work *Correspondence: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/768242; this version posted September 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract GSK3β is a multifunctional kinase that phosphorylates β-catenin in the Wnt signaling network and also acts on other protein targets in response to distinct cellular signals. To test the long-standing hypothesis that the scaffold protein Axin specifically accelerates β-catenin phosphorylation, we measured GSK3β reaction rates with multiple substrates in a minimal, biochemically-reconstituted system. We observed an unexpectedly small, ~2-fold Axin-mediated rate increase for the β-catenin reaction. The much larger effects reported previously may have arisen because Axin can rescue GSK3β from an inactive state that occurs only under highly specific conditions. -
Harnessing Low-Density Lipoprotein Receptor Protein 6 (LRP6) Genetic Variation and Wnt Signaling for Innovative Diagnostics in Complex Diseases
OPEN The Pharmacogenomics Journal (2018) 18, 351–358 www.nature.com/tpj REVIEW Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases Z-M Wang1,2, J-Q Luo1,2, L-Y Xu3, H-H Zhou1,2 and W Zhang1,2 Wnt signaling regulates a broad variety of processes in both embryonic development and various diseases. Recent studies indicated that some genetic variants in Wnt signaling pathway may serve as predictors of diseases. Low-density lipoprotein receptor protein 6 (LRP6) is a Wnt co-receptor with essential functions in the Wnt/β-catenin pathway, and mutations in LRP6 gene are linked to many complex human diseases, including metabolic syndrome, cancer, Alzheimer’s disease and osteoporosis. Therefore, we focus on the role of LRP6 genetic polymorphisms and Wnt signaling in complex diseases, and the mechanisms from mouse models and cell lines. It is also highly anticipated that LRP6 variants will be applied clinically in the future. The brief review provided here could be a useful resource for future research and may contribute to a more accurate diagnosis in complex diseases. The Pharmacogenomics Journal (2018) 18, 351–358; doi:10.1038/tpj.2017.28; published online 11 July 2017 INTRODUCTION signaling pathways and expressed in various target organs.1 LDLR- The Wnt1 gene was identified in 1982. Ensuing studies in related proteins 5/6 (LRP5/6) belong to this large family and Drosophila and Xenopus unveiled a highly conserved Wnt/ function as co-receptors of the Wnt/β-catenin pathway. These β-catenin pathway, namely, canonical Wnt signaling. -
The LRP6 Rs2302685 Polymorphism Is Associated with Increased Risk Of
Xu et al. Lipids in Health and Disease 2014, 13:94 http://www.lipidworld.com/content/13/1/94 RESEARCH Open Access The LRP6 rs2302685 polymorphism is associated with increased risk of myocardial infarction Shun Xu1,2,3, Jie Cheng1,2,3, Yu-ning Chen1,2,3, Keshen Li4, Ze-wei Ma1,2, Jin-ming Cen5, Xinguang Liu1,2,3, Xi-li Yang5, Can Chen6 and Xing-dong Xiong1,2,3* Abstract Background: Abnormal lipids is one of the critical risk factors for myocardial infarction (MI), however the role of genetic variants in lipid metabolism-related genes on MI pathogenesis still requires further investigation. We herein genotyped three SNPs (LRP6 rs2302685, LDLRAP1 rs6687605, SOAT1 rs13306731) in lipid metabolism-related genes, aimed to shed light on the influence of these SNPs on individual susceptibility to MI. Methods: Genotyping of the three SNPs (rs2302685, rs6687605 and rs13306731) was performed in 285 MI cases and 650 control subjects using polymerase chain reaction–ligation detection reaction (PCR–LDR) method. The association of these SNPs with MI and lipid profiles was performed with SPSS software. Results: Multivariate logistic regression analysis showed that C allele (OR = 1.62, P = 0.039) and the combined CT/CC genotype (OR = 1.67, P = 0.035) of LRP6 rs2302685 were associated with increased MI risk, while the other two SNPs had no significant effect. Further stratified analysis uncovered a more evident association with MI risk among younger subjects (≤60 years old). Fascinatingly, CT/CC genotype of rs2302685 conferred increased LDL-C levels compared to TT genotype (3.0 mmol/L vs 2.72 mmol/L) in younger subjects. -
Multi-Modal Meta-Analysis of 1494 Hepatocellular Carcinoma Samples Reveals
Author Manuscript Published OnlineFirst on September 21, 2018; DOI: 10.1158/1078-0432.CCR-18-0088 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Multi-modal meta-analysis of 1494 hepatocellular carcinoma samples reveals significant impact of consensus driver genes on phenotypes Kumardeep Chaudhary1, Olivier B Poirion1, Liangqun Lu1,2, Sijia Huang1,2, Travers Ching1,2, Lana X Garmire1,2,3* 1Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, USA 2Molecular Biosciences and Bioengineering Graduate Program, University of Hawaii at Manoa, Honolulu, HI 96822, USA 3Current affiliation: Department of Computational Medicine and Bioinformatics, Building 520, 1600 Huron Parkway, Ann Arbor, MI 48109 Short Title: Impact of consensus driver genes in hepatocellular carcinoma * To whom correspondence should be addressed. Lana X. Garmire, Department of Computational Medicine and Bioinformatics Medical School, University of Michigan Building 520, 1600 Huron Parkway Ann Arbor-48109, MI, USA, Phone: +1-(734) 615-5510 Current email address: [email protected] Grant Support: This research was supported by grants K01ES025434 awarded by NIEHS through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative (http://datascience.nih.gov/bd2k), P20 COBRE GM103457 awarded by NIH/NIGMS, NICHD R01 HD084633 and NLM R01LM012373 and Hawaii Community Foundation Medical Research Grant 14ADVC-64566 to Lana X Garmire. 1 Downloaded from clincancerres.aacrjournals.org on October 1, 2021. © 2018 American Association for Cancer Research. Author Manuscript Published OnlineFirst on September 21, 2018; DOI: 10.1158/1078-0432.CCR-18-0088 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. -
Astrocytic LRP1 Mediates Brain Aßclearance and Impacts Amyloid
The Journal of Neuroscience, April 12, 2017 • 37(15):4023–4031 • 4023 Neurobiology of Disease Astrocytic LRP1 Mediates Brain A Clearance and Impacts Amyloid Deposition Chia-Chen Liu,1 Jin Hu,1,3 Na Zhao,1 XJian Wang,1 Na Wang,1,3 XJohn R. Cirrito,2 Takahisa Kanekiyo,1 David M. Holtzman,2 and Guojun Bu1,3 1Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, 2Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer’s Disease Research Center, Washington University School of Medicine, St. Louis, Missouri 63110, and 3Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, College of Medicine, Xiamen University, Xiamen, Fujian, 361102 China Accumulation and deposition of amyloid- (A) in the brain represent an early and perhaps necessary step in the pathogenesis of Alzheimer’s disease (AD). A accumulation leads to the formation of A aggregates, which may directly and indirectly lead to eventual neurodegeneration. While A production is accelerated in many familial forms of early-onset AD, increasing evidence indicates that impaired clearance of A is more evident in late-onset AD. To uncover the mechanisms underlying impaired A clearance in AD, we examined the role of low-density lipoprotein receptor-related protein 1 (LRP1) in astrocytes. Although LRP1 has been shown to play critical roles in brain A metabolism in neurons and vascular mural cells, its role in astrocytes, the most abundant cell type in the brain responsible for maintaining neuronal homeostasis, remains unclear. Here, we show that astrocytic LRP1 plays a critical role in brain A clearance. LRP1 knockdown in primary astrocytes resulted in decreased cellular A uptake and degradation. -
RISK ASSESSMENT and DIAGNOSIS for EARLY ATHEROSCLEROSIS
RISK ASSESSMENT and DIAGNOSIS for 84 EARLY ATHEROSCLEROSIS/DYSLIPIDEMIAS [Genes ] AtheroGxOne™ is a genetic test to detect mutations responsible for monogenic diseases of early atherosclerosis. • Panel genes affect plasma levels of lipids (total cholesterol, LDL, HDL, triglycerides) and blood sugar. • Targeted diseases have a high impact on cardiovascular risk since they appear at an early age and indicate poor prognosis without aggressive medical intervention. • The probability of identifying the responsible mutation in patients who meet clinical criteria of familial hypercholesterolemia ranges from 60% to 80%.1,2,3 Panel Designed For Patients Who Have Or May Have: AtheroGxOneTM Gene List • Premature coronary artery disease (men < 50 years old; women < 60 years old) ABCA1 CIDEC KLF11 PDX1 • Suspected Familial Hypercholesterolemia ABCB1 COQ2 LCAT PLIN1 • Suspected Familial Hypertriglyceridemia ABCG1 CPT2 LDLR PLTP • Mixed Hyperlipidemias ABCG5 CYP2D6 LDLRAP1 PNPLA2 • Abnormally high LDL levels or low HDL ABCG8 CYP3A4 LEP PPARA • Maturity-Onset Diabetes of the Young (MODY) AGPAT2 CYP3A5 LIPA PPARG AKT2 EIF2AK3 LIPC PTF1A AMPD1 FOXP3 LMF1 PTRF ANGPTL3 GATA6 LMNA PYGM APOA1 GCK LPA RFX6 APOA5 GLIS3 LPL RYR1 APOB GPD1 LRP6 SAR1B APOC2 GPIHBP1 MEF2A SCARB1 APOC3 HNF1A MTTP SLC22A8 APOE HNF1B MYLIP SLC25A40 BLK HNF4A NEUROD1 SLC2A2 BSCL2 IER3IP1 NEUROG3 SLCO1B1 CAV1 INS NPC1L1 TBC1D4 CEL INSIG2 PAX4 TRIB1 CETP INSR PCDH15 WFS1 Atherosclerosis is defined as the buildup of plaque within arteries CH25H KCNJ11 PCSK9 ZMPSTE24 that can lead to heart attack, stroke, or even death. Approximately, 5% of cardiac arrests in individuals younger than 60 years old can be attributed to genetic mutations included in this panel; this number rises up to 20% in individuals younger than 45 years old.4,5 1. -
Deletions of AXIN1, a Component of the WNT/Wingless Pathway, in Sporadic Medulloblastomas1
[CANCER RESEARCH 61, 7039–7043, October 1, 2001] Advances in Brief Deletions of AXIN1, a Component of the WNT/wingless Pathway, in Sporadic Medulloblastomas1 R. P. Dahmen, A. Koch, D. Denkhaus, J. C. Tonn, N. So¨rensen, F. Berthold, J. Behrens, W. Birchmeier, O. D. Wiestler, and T. Pietsch2 Department of Neuropathology, University of Bonn Medical Center, D-53105 Bonn, Germany [R. P. D., A. K., D. D., O. D. W., T. P.]; Department of Neurosurgery at the Ludwig Maximilian University in Munich, D-81377 Munich, Germany [J. C. T.]; Department of Pediatric Neurosurgery, University of Wu¨rzburg, D-97080 Wu¨rzburg, Germany [N. S.]; Department of Pediatric Hematology/Oncology, University of Cologne, D-50924 Cologne, Germany [F. B.]; Department of Experimental Medicine II, University of Erlangen- Nu¨rnberg, D-91054 Erlangen, Germany [J. B.]; and Max-Delbru¨ck-Center for Molecular Medicine, D-13092 Berlin, Germany [W. B.] Abstract particular, mutations of -catenin and APC lead to constitutive sta- bilization of -catenin. Mutations of -catenin (5% of cases) and APC Medulloblastoma (MB) represents the most frequent malignant brain (4%) as components of the WNT pathway have been identified pre- tumor in children. Most MBs appear sporadically; however, their inci- viously in sporadic MBs (20–24). dence is highly elevated in two inherited tumor predisposition syndromes, Gorlin’s and Turcot’s syndrome. The genetic defects responsible for these Axin was initially identified as the gene product of the mouse fused diseases have been identified. Whereas Gorlin’s syndrome patients carry locus, which negatively regulates WNT signaling (25). Recent exper- germ-line mutations in the patched (PTCH) gene, Turcot’s syndrome iments demonstrate that Axin functions as a tumor suppressor in HCC patients with MBs carry germ-line mutations of the adenomatous polyposis (26). -
TSC1/2 Mutations—A Unique Type of Mutation Suitable for Liver Transplantation of Hepatocellular Carcinoma
1085 Original Article TSC1/2 mutations—a unique type of mutation suitable for liver transplantation of Hepatocellular carcinoma Jinming Wei1#, Linsen Ye1#, Laien Song1#, Hui Tang2, Tong Zhang2, Binsheng Fu2, Yingcai Zhang2, Qing Yang2, Yang Yang2, Shuhong Yi2 1Guangdong Provincial Key Laboratory of Liver Disease Research, Guangzhou, China; 2Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China Contributions: (I) Conception and design: J Wei, L Ye, S Yi; (II) Administrative support: Y Yang; (III) Provision of study materials or patients: L Song; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Yang Yang, Shuhong Yi. Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Email: [email protected]; [email protected]. Background: This study aimed to investigate the relationship between the prognosis of patients with hepatocellular carcinoma (HCC) after liver transplantation and mammalian target of rapamycin (mTOR) pathway-related genes-TSC1/2. Methods: We retrospectively analyzed the clinical data of 46 patients who underwent liver transplantation for HCC and performed next generation sequencing to analyze the relationship between the efficacy of sirolimus after liver transplantation for HCC and mutations in mTOR pathway-related genes, especially tuberous sclerosis complex (TSC) mutations. Results: The average age of 46 patients with liver transplantation for HCC was 51±21 years. After surgery, 35 patients received an anti-rejection/anti-tumor regimen that included sirolimus, and 11 patients did not receive sirolimus. -
TRAP1 Regulates Wnt/-Catenin Pathway Through LRP5/6 Receptors
International Journal of Molecular Sciences Article TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation 1, 1, 1 1 Giacomo Lettini y, Valentina Condelli y, Michele Pietrafesa , Fabiana Crispo , Pietro Zoppoli 1 , Francesca Maddalena 1, Ilaria Laurenzana 1 , Alessandro Sgambato 1, Franca Esposito 2,* and Matteo Landriscina 1,3,* 1 Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, 85028 Rionero in Vulture, PZ, Italy; [email protected] (G.L.); [email protected] (V.C.); [email protected] (M.P.); [email protected] (F.C.); [email protected] (P.Z.); [email protected] (F.M.); [email protected] (I.L.); [email protected] (A.S.) 2 Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy 3 Medical Oncology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71100 Foggia, Italy * Correspondence: [email protected] (F.E.); [email protected] (M.L.); Tel.: +39-081-7463-145 (F.E.); +39-0881-736-426 (M.L.) These authors have contributed equally to this work. y Received: 4 September 2020; Accepted: 10 October 2020; Published: 13 October 2020 Abstract: Wnt/β-Catenin signaling is involved in embryonic development, regeneration, and cellular differentiation and is responsible for cancer stemness maintenance. The HSP90 molecular chaperone TRAP1 is upregulated in 60–70% of human colorectal carcinomas (CRCs) and favors stem cells maintenance, modulating the Wnt/β-Catenin pathway and preventing β-Catenin phosphorylation/degradation. The role of TRAP1 in the regulation of Wnt/β-Catenin signaling was further investigated in human CRC cell lines, patient-derived spheroids, and CRC specimens. -
TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy
Pharmacogenomics and Personalized Medicine Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy This article was published in the following Dove Press journal: Pharmacogenomics and Personalized Medicine Kangjian Song Purpose: To explore the value of Tuberous sclerosis complex 2 (TSC2) mutations in Fu He evaluating the early recurrence of hepatocellular carcinoma (HCC) patients underwent Yang Xin hepatectomy. Ge Guan Patients and Methods: A total of 183 HCC patients were enrolled. Next-generation Junyu Huo sequencing was performed on tumor tissues to analyze genomic alterations, tumor mutational burden and variant allele fraction (VAF). The associations between TSC2 mutations and Qingwei Zhu recurrence rate within 1 year, RFS and OS after hepatectomy were analyzed. Ning Fan Results: Our results showed that TSC2 mutation frequency in HCC was 12.6%. Yuan Guo Compared to patients without TSC2 mutation, the proportion of microvascular invasion Yunjin Zang (MVI) and Edmondson grade III–IV was significantly higher in patients with a TSC2 Liqun Wu mutation (p<0.05). The VAF of mutated TSC2 was higher in patients with maximum Liver Disease Center, The Affiliated diameter of tumor >5cm or MVI than that of other patients (p<0.05). The frequency of Hospital of Qingdao University, Qingdao, TP53 mutation was significantly higher in patients with a TSC2 mutation than those 266003, People’s Republic of China without TSC2 mutation (p=0.003). Follow-up analysis showed that patients with a TSC2 mutation had significantly higher recurrence rate within 1 year (p=0.015) and poorer median recurrence-free survival (RFS) (p=0.010) than patients without TSC2 mutation. -
Modulation of LRP6-Mediated Wnt Signaling by Molecular Chaperone Mesd
FEBS Letters 580 (2006) 5423–5428 Modulation of LRP6-mediated Wnt signaling by molecular chaperone Mesd Yonghe Lia,b,*, Wenyan Lua,b,XiHec, Guojun Bua,d a Department of Pediatrics, Washington University School of Medicine and St. Louis Children’s Hospital, St. Louis, MO 63110, USA b Department of Biochemistry and Molecular Biology, Drug Discovery Division, Southern Research Institute, Birmingham, AL 35205, USA c Division of Neuroscience, Children’s Hospital, Department of Neurology, Harvard Medical School, Boston, MA 02115, USA d Department of Cell Biology and Physiology, Washington University School of Medicine, MO 63110, USA Received 3 May 2006; revised 1 September 2006; accepted 7 September 2006 Available online 18 September 2006 Edited by Lukas Huber ligands for other LDLR family members typically bind to Abstract LRP6 is a Wnt coreceptor at the cell surface. Here, we report that a specialized molecular chaperone Mesd modu- the clusters of ligand-binding repeats [2,3]. lates LRP6-mediated Wnt signaling and how different LRP6 A common feature that is shared by most members of the mutants exhibit differential effects on Wnt signaling. We found LDLR family is their ability to bind the receptor-associated that overexpression of increasing amounts of the full-length protein (RAP) [11]. RAP is an endoplasmic reticulum (ER)- LRP6 enhances Wnt signaling in a dose dependent manner only resident protein that functions in receptor folding and traffick- in the presence of a co-expression of the molecular chaperone ing along the secretory pathway. Upon binding to receptors Mesd, which promotes LRP6 folding and maturation to the cell following their translation, RAP promotes receptor folding.